4'-去甲基表鬼臼毒素9-(4,6-O-亚乙基-β-D-吡喃葡萄糖苷)（VP 16-213，NSC 141540）联合化疗治疗L1210白血病 - Suppr

Suppr

超能文献

Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.

作者信息

Dombernowsky P, Nissen N I

出版信息

Eur J Cancer (1965). 1976 Mar;12(3):181-8. doi: 10.1016/0014-2964(76)90239-5.

DOI:10.1016/0014-2964(76)90239-5

PMID:939236

Abstract

摘要

相似文献

Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.4'-去甲基表鬼臼毒素9-(4,6-O-亚乙基-β-D-吡喃葡萄糖苷)（VP 16-213，NSC 141540）联合化疗治疗L1210白血病

Eur J Cancer (1965). 1976 Mar;12(3):181-8. doi: 10.1016/0014-2964(76)90239-5.

Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.AKR淋巴瘤与人类血液肿瘤的化疗比较

Cancer Res. 1974 Jan;34(1):184-93.

The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.

Chemotherapy. 1973;18(3):169-83. doi: 10.1159/000221259.

Combination chemotherapy in malignant diseases.恶性疾病的联合化疗

J R Coll Physicians Lond. 1971 Jan;5(2):167-77.

Electronic volume analysis of L1210 chemotherapy.L1210化疗的电子体积分析

Cancer Res. 1976 Dec;36(12):4434-8.

Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.

J Natl Cancer Inst. 1976 Dec;57(6):1363-6. doi: 10.1093/jnci/57.6.1363.

[1973 treatment of acute leukemias].[1973年急性白血病的治疗]

Minerva Med. 1974 Dec 15;65(90):4742-53.

The treatment of acute lymphocytic leukemia.急性淋巴细胞白血病的治疗。

J Chronic Dis. 1970 Mar;22(10):633-5. doi: 10.1016/0021-9681(70)90077-9.

Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.L1210对阿糖胞苷与VM-26或VP16-213联合用药的反应。

Eur J Cancer (1965). 1975 Sep;11(9):639-47. doi: 10.1016/0014-2964(75)90099-7.

Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.不同剂量的甲氨蝶呤（NSC - 740）、阿糖胞苷（NSC - 63878）和环磷酰胺（NSC - 26271）对L1210白血病小鼠耐药性的影响。

Cancer Chemother Rep. 1972 Aug;56(4):473-81.

引用本文的文献

Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies.口服联合化疗在艾滋病相关淋巴增殖性恶性肿瘤治疗中的应用

Drugs. 1999;58 Suppl 3:99-107. doi: 10.2165/00003495-199958003-00014.

Cyclophosphamide and etoposide for non-small cell and small cell lung cancer.环磷酰胺和依托泊苷用于非小细胞肺癌和小细胞肺癌。

Drugs. 1999;58 Suppl 3:11-5. doi: 10.2165/00003495-199958003-00002.

Current development of podophyllotoxins.鬼臼毒素的当前发展情况。

Cancer Chemother Pharmacol. 1982;7(2-3):93-8. doi: 10.1007/BF00254528.

[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].依托泊苷（VP 16-213）——一种具有高抗肿瘤活性的鬼臼毒素衍生物（作者译）

Klin Wochenschr. 1981 Nov 2;59(21):1177-88. doi: 10.1007/BF01721212.

Synergistic antitumor activity of vincristine and VP-16-213.长春新碱与依托泊苷的协同抗肿瘤活性。

Cancer Chemother Pharmacol. 1984;13(3):176-80. doi: 10.1007/BF00269024.

Pharmacokinetics of anticancer drugs in children.儿童抗癌药物的药代动力学

Clin Pharmacokinet. 1987 Mar;12(3):168-213. doi: 10.2165/00003088-198712030-00002.

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.依托泊苷。对其药效学和药代动力学特性以及在癌症联合化疗中的治疗潜力的综述。

Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008.

Podophyllotoxin derivative VP 16-213.鬼臼毒素衍生物VP 16 - 213

Cancer Chemother Pharmacol. 1979;3(2):71-80. doi: 10.1007/BF00254976.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验